Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With MSN Laboratories Pvt. Ltd.

BOCA RATON, Fla., Dec. 19, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product agreement with MSN Laboratories Pvt. Ltd. (Hyderabad, India) under which Breckenridge and MSN expect to commercialize several new ANDAs.  Under the terms of the agreement, MSN will develop, manufacture, and supply the products exclusively to Breckenridge for the U.S. market, and Breckenridge will market and distribute the products under its label.  Breckenridge and MSN have agreed to develop an oral antibiotic with current U.S. brand sales of $644 Million USD, and a cardiovascular drug with current U.S. generic sales of $35 Million USD.  This agreement contemplates the filing of multiple first-to-file Paragraph IV ANDAs. 

Prior to entering into the new agreement, Breckenridge and MSN were already engaged in the collaborative development and prosecution of two first-to-file Paragraph IV ANDAs that have been submitted to and are pending with FDA.  The collaborative effort between Breckenridge and MSN reflects Breckenridge's larger focus on high-value, niche opportunities.  To date through 2014, Breckenridge has filed more than twenty-three (23) Paragraph IV patent challenges and intends to continue that trend in the next several years, focusing on niche and first-to-file Paragraph IV opportunities with certain barriers to entry.

About Breckenridge:
Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products in many therapeutic categories.  The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide.  The company markets products in a variety of dosage forms including:  Drops, Tablets, Capsules, Syrups, Solutions, and Powders. 
www.bpirx.com

About MSN Laboratories:
MSN Laboratories Pvt. Ltd., is a privately-held developer and manufacturer of finished dosed drug products and active pharmaceutical ingredients, holding over 130 DMFs for the United States market. Founded in 2003 and with manufacturing facilities located in Hyderebad, India, MSN is one of the fastest growing research-based pharmaceutical companies in India, serving customers worldwide.
www.msnlabs.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/breckenridge-pharmaceutical-signs-multi-product-generic-agreement-with-msn-laboratories-pvt-ltd-300012642.html

SOURCE Breckenridge Pharmaceutical, Inc.

Help employers find you! Check out all the jobs and post your resume.

Back to news